Efficacy of 7 day lansoprazole‐based triple therapy for Helicobacter pylori infection in elderly patients

Background: The prevalence of Helicobacter pylori increases with age. However, data regarding the effects of anti‐H. pylori treatments in the elderly are very scarce.

[1]  A. Pilotto,et al.  The Long-Term Clinical Outcome of Elderly Patients with Helicobacter pylori-Associated Peptic Ulcer Disease , 1998, Gerontology.

[2]  D. Forman,et al.  Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group. , 1997, Gut.

[3]  Jaup Bk.  Duodenal ulcer healing after 7-day treatment: a pilot study with lansoprazole, amoxicillin, and clarithromycin. , 1996 .

[4]  A. Weissfeld,et al.  Seven‐Day Triple Therapy with Lansoprazole, Clarithromycin, and Metronidazole for the Cure of Helicobacter pylori Infection: A Short Report , 1996, Helicobacter.

[5]  A. Pilotto,et al.  Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers , 1996, Alimentary pharmacology & therapeutics.

[6]  M. Walker,et al.  Lansoprazole, clarithromycin and metronidazole for seven days in Helicobacter pylori infection , 1996, Alimentary pharmacology & therapeutics.

[7]  M. Montalto,et al.  Helicobacter pylori eradication using one‐week low‐dose lansoprazole plus amoxycillin and either clarithromycin or azithromycin , 1996, Alimentary pharmacology & therapeutics.

[8]  A. Pilotto,et al.  The Clinical Usefulness of Serum Pepsinogens, Specific IgG Anti‐HP Antibodies and Gastrin for Monitoring Helicobacter pylori Treatment in Older People , 1996, Journal of the American Geriatrics Society.

[9]  F. Di Mario,et al.  Helicobacter pylori infection in asymptomatic elderly subjects living at home or in a nursing home: effects on gastric function and nutritional status. , 1996, Age and ageing.

[10]  E. Hahn,et al.  One week treatment with omeprazole, clarithromycin and tinidazole or lansoprazole, amoxicillin and metronidazole for cure of Helicobacter pylori infection in duodenal ulcer patients. , 1996, Journal of Physiology and Pharmacology.

[11]  D. Graham,et al.  Medical treatment of peptic ulcer disease : practice guidelines , 1996 .

[12]  Soll Ah.  Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology. , 1996 .

[13]  B. Jaup,et al.  Comparison of two low-dose one-week triple therapy regimens with and without metronidazole for cure of H. pylori infection. , 1995, Alimentary Pharmacology and Therapeutics.

[14]  A. Soll.  Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology. , 1996, JAMA.

[15]  K. Schütze,et al.  Duodenal ulcer healing after 7-day treatment: a pilot study with lansoprazole, amoxicillin and clarithromycin. , 1995, Zeitschrift fur Gastroenterologie.

[16]  S. Ito,et al.  Lansoprazole Treatment of Helicobacter pylori- Positive Peptic Ulcers , 1995, Journal of Clinical Gastroenterology.

[17]  B. Jaup,et al.  Low dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers. , 1995, The American journal of gastroenterology.

[18]  R. Genta,et al.  Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection , 1995, Alimentary pharmacology & therapeutics.

[19]  M. Murakami,et al.  Therapeutic Effects of Lansoprazole on Peptic Ulcers in Elderly Patients , 1995, Journal of clinical gastroenterology.

[20]  M. Stolte,et al.  One-week low-dose triple therapy for the eradication of Helicobacter pylori infection. , 1995, European journal of gastroenterology & hepatology.

[21]  F. Bazzoli,et al.  Short‐term low‐dose triple therapy for the eradication of Helicobacter pylori , 1994 .

[22]  M. Rugge,et al.  Pathology of the gastric antrum and body associated with Helicobacter pylori infection in non‐ulcerous patients: is the bacterium a promoter of intestinal metaplasia? , 1993, Histopathology.

[23]  P. Mainguet,et al.  [The "Sidney System", a new classification of gastritis]. , 1993, Gastroenterologie clinique et biologique.

[24]  J. Crabtree,et al.  Helicobacter pylori, gastritis, and peptic ulceration in the elderly. , 1992, Journal of Clinical Pathology.

[25]  M. Blaser,et al.  Serodiagnosis of Helicobacter pylori: comparison of enzyme-linked immunosorbent assays , 1991, Journal of clinical microbiology.

[26]  F. Mégraud,et al.  Activity of lansoprazole against Helicobacter pylori , 1991, The Lancet.

[27]  D. Graham,et al.  Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. , 1991, Gastroenterology.

[28]  H. Satoh,et al.  Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori , 1991, Antimicrobial Agents and Chemotherapy.

[29]  D. Graham,et al.  Gastritis in the elderly. , 1990, Gastroenterology clinics of North America.

[30]  E. Palmer.  Ulcer disease in the elderly. , 1974, American Family Physician.